These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Melanoma Imaging Using Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486 [TBL] [Abstract][Full Text] [Related]
29. Effects of the amino acid linkers on the melanoma-targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-MSH peptides. Guo H; Yang J; Gallazzi F; Miao Y J Nucl Med; 2011 Apr; 52(4):608-16. PubMed ID: 21421725 [TBL] [Abstract][Full Text] [Related]
30. Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH. Wei L; Zhang X; Gallazzi F; Miao Y; Jin X; Brechbiel MW; Xu H; Clifford T; Welch MJ; Lewis JS; Quinn TP Nucl Med Biol; 2009 May; 36(4):345-54. PubMed ID: 19423001 [TBL] [Abstract][Full Text] [Related]
31. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases. Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683 [TBL] [Abstract][Full Text] [Related]